title: Borna disease virus infection in cats: ABCD guidelines on prevention and management.
abstract: BACKGROUND
  Borna disease virus (BDV) has a broad host range, affecting primarily horses and sheep, but also cattle, ostriches, cats and dogs. In cats, BDV may cause a non-suppurative meningoencephalomyelitis ('staggering disease').
  
  
  BACKGROUND
  The mode of transmission is not completely elucidated. Direct and indirect virus transmission is postulated, but BDV is not readily transmitted between cats. Vectors such as ticks may play a role and shrews have been identified as a potential reservoir host. Access to forested areas has been reported to be an important risk factor for staggering disease.
  
  
  METHODS
  It is postulated that BDV may infect nerve endings in the oropharynx and spread via olfactory nerve cells to the central nervous system. A strong T-cell response may contribute to the development of clinical disease. Affected cats develop gait disturbances, ataxia, pain in the lower back and behavioural changes.
  
  
  METHODS
  For diagnostic purposes, detection of viral RNA by reverse transcription PCR in samples collected from cats with clinical signs of Borna disease can be considered diagnostic. Serology is of little value; cats without signs of Borna disease may be seropositive and yet not every cat with BDV infection has detectable levels of antibodies.
  A hypothesis that BDV infection may be involved in the development of selected neurological disorders in man could not be confirmed. A research group within the German Robert Koch Institute studied the potential health threat of BDV to humans and concluded that BDV was not involved in the aetiology of human psychiatric diseases.
authors.forename: Hans
authors.initials: H
authors.lastname: Lutz
authors.forename: Diane D
authors.initials: DD
authors.lastname: Addie
authors.forename: Corine
authors.initials: C
authors.lastname: Boucraut-Baralon
authors.forename: Herman
authors.initials: H
authors.lastname: Egberink
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Frymus
authors.forename: Tim
authors.initials: T
authors.lastname: Gruffydd-Jones
authors.forename: Katrin
authors.initials: K
authors.lastname: Hartmann
authors.forename: Marian C
authors.initials: MC
authors.lastname: Horzinek
authors.forename: Margaret J
authors.initials: MJ
authors.lastname: Hosie
authors.forename: Albert
authors.initials: A
authors.lastname: Lloret
authors.forename: Fulvio
authors.initials: F
authors.lastname: Marsilio
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Pennisi
authors.forename: Alan D
authors.initials: AD
authors.lastname: Radford
authors.forename: Etienne
authors.initials: E
authors.lastname: Thiry
authors.forename: Uwe
authors.initials: U
authors.lastname: Truyen
authors.forename: Karin
authors.initials: K
authors.lastname: Möstl
mesh_terms: D000827:Animal Welfare / Q000592:standards*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001890:Borna Disease / Q000175:diagnosis / Q000517:prevention & control*; D001891:Borna disease virus / Q000302:isolation & purification*; D002371:Cat Diseases / Q000175:diagnosis / Q000517:prevention & control* / Q000821:virology; D002415:Cats; D006799:Housing, Animal / Q000592:standards*; D006801:Humans; D008297:Male; D014730:Veterinary Medicine / Q000592:standards; D015047:Zoonoses / Q000821:virology*
chemical_list: D000914:Antibodies, Viral